Option Care Health Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Option Care Health Inc in the first quarter 2026?
Option Care Health Inc achieved a return on average equity (ROE) of 15.28 % in its first quarter 2026, this is above OPCH's average return on equity of -120.81%.
Option Care Health Inc shareholder's equity over the 12 months ending in its first quarter 2026 are valued at $1,349 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Healthcare Facilities industry 12 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2025 from 694 to 925.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Equity Change	0.02 %	-5.54 %	-4.74 %	-3.65 %	-
Y / Y Net Income Change	-2.99 %	-2.71 %	-3.79 %	-4.75 %	4.36 %
Net Income (TTM) in Millions	206	208	209	211	214
Return On Equity (TTM)	15.28 %	15.39 %	15.29 %	15.25 %	15.29 %
OPCH's Total Ranking	# 925	# 694	# 823	# 326	# 756
Equity (TTM) in Millions	1,351	1,326	1,359	1,360	1,351
Seq. Equity Change	1.86 %	-2.37 %	-0.09 %	0.67 %	-3.8 %
Seq. Net Income Change	-22.5 %	12.91 %	2.56 %	8.09 %	-22.27 %

Back to OPCH Management Effectiveness >> OPCH's 5 Years Annual ROE >> Compare OPCH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 13
Sector	# 107
Overall	# 925

Return On Equity Statistics
High	Average	Low
32.78 %	-120.81 %	-6337.64 %
(Jun 30 2012)		(Dec 31 2015)

OPCH Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	1,326	1,404	1,422	1,386	1,176
Y / Y Equity Change	-5.54 %	-1.23 %	2.57 %	17.88 %	15.77 %
Net Income in Millions	208	212	267	151	140
Y / Y Net Income Change	-2 %	-20.69 %	77.4 %	7.62 %	-
Return On Equity	15.65 %	15.08 %	18.79 %	10.86 %	11.9 %

Back to OPCH Management Effectiveness >> OPCH's 5 Years Annual ROE >> Compare OPCH ROE to its Competitors

Annual Roe Comment

Despite deterioration in net income, company improved ROE to in 2025, company improved ROE to 15.65 % compared to the prior year.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
OPCH's' Return on Equity at Yahoo Finance
OPCH's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for OPCH's Competitors
Subscribers only: Roe for Option Care Health Inc 's Suppliers
Subscribers only: Return On Equity for OPCH's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector	ROE
Transmedics Group Inc	41.92 %
Abeona Therapeutics Inc	41.40 %
Apellis Pharmaceuticals Inc	39.71 %
Adma Biologics Inc	38.97 %
Bristol myers Squibb Company	38.94 %
Acadia Pharmaceuticals Inc	35.65 %
Spero Therapeutics Inc	35.58 %
Illumina Inc	33.99 %
Dexcom Inc	33.83 %
Rafael Holdings Inc	31.93 %
Solventum Corporation	30.71 %
Phibro Animal Health Corporation	30.60 %
Pro dex Inc	30.01 %
Incyte Corporation	29.20 %
Protalix Biotherapeutics inc	28.10 %
Collegium Pharmaceutical Inc	26.74 %
Pacs Group Inc	26.46 %
Johnson and Johnson	26.26 %
Engene Therapeutics Inc	25.83 %
Encompass Health Corporation	25.56 %
Chemed Corporation	25.33 %
Resmed Inc	24.76 %
Iradimed Corporation	24.48 %
Lantheus Holdings Inc	24.33 %
Prestige Consumer Healthcare Inc	24.20 %
Vertex Pharmaceuticals Inc	23.93 %
Catalyst Pharmaceuticals Inc	23.65 %
Xoma Royalty Corporation	23.64 %
Soleno Therapeutics Inc	22.85 %
Electromed Inc	22.41 %

Date modified: 2026-09-26T07:16:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.